• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, May 21, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Tumor microenvironment acts as a mechanism of resistance to chemotherapy

Bioengineer by Bioengineer
September 6, 2016
in Cancer
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Researchers at Bellvitge Biomedical Research Institute (IDIBELL) have published a new Oncotarget work which highlights the importance of the tumor environment as a source of resistance to treatment in colorectal cancer, the fourth most common cancer and the leading cause of cancer death worldwide. The article describes how the presence of certain molecules in the environment of the tumor triggers processes that protect the tumor cells from the action of conventional chemotherapy. Resistance to treatment is one of the main obstacles that patients face during the course of the disease; therefore, understand the mechanisms by which it develops is essential to improve the prognosis.

The study led by Dr David G. Molleví, researcher of the Program against cancer therapeutic resistance (PROCURE) of IDIBELL, reports how certain cytokines, chemokines and other soluble factors secreted by carcinoma associated fibroblasts (CAFs), a type of normal cell which is closely associated with primary tumor cells, induce processes that slow down cell cycle, affecting the proliferation of tumor cells. In the presence of conventional chemotherapy, such factors allow stabilization and activation of selected downstream proteins that minimize the effectiveness of the treatment. However, it has also been reported that inhibition of the JAK/STAT signaling pathway, addict to many of these cytokines, might revert the process.

The importance of tumor microenvironment (TME) as a relevant contributor to cancer progression and its role in the development of resistance to therapies has become increasingly apparent to researchers. “Although current cancer research mainly focuses on therapies against specific targets, most tumors are still treated with conventional cytotoxic therapies, so drug resistance remains the main obstacle to their success” explains Dr Molleví.

“From a clinical perspective, identifying the soluble factors that mediate such microenvironment-mediated drug resistance might yield valuable information to circumvent it”, says Dr Molleví;. “Hampering key common, nomal cells responsible for the synthesis of such factors might be an interesting approach to avoid the protective effect exerted by such molecules and to render tumor cells sensitive to chemotherapy”.

###

Media Contact

Gemma Fornons
[email protected]
34-638-685-074
@idibell_en

http://www.idibell.cat

The post Tumor microenvironment acts as a mechanism of resistance to chemotherapy appeared first on Scienmag.

Share12Tweet7Share2ShareShareShare1

Related Posts

James Bibb

Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders

May 20, 2022
Oncotarget | Anti-Cancer Drug Profiling With CancerOmicsNet

Oncotarget | Anti-cancer drug profiling with CancerOmicsNet

May 19, 2022

New CMJ Review explores the metabolic dysfunction associated fatty liver disease

May 19, 2022

Aging-US: Hallmarks of cancer and hallmarks of aging reviewed

May 18, 2022
Please login to join discussion

POPULAR NEWS

  • Weybourne Atmospheric Observatory

    Breakthrough in estimating fossil fuel CO2 emissions

    46 shares
    Share 18 Tweet 12
  • Hidden benefit: Facemasks may reduce severity of COVID-19 and pressure on health systems, researchers find

    44 shares
    Share 18 Tweet 11
  • Discovery of the one-way superconductor, thought to be impossible

    43 shares
    Share 17 Tweet 11
  • Sweet discovery could drive down inflammation, cancers and viruses

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Violence/CriminalsUniversity of WashingtonVaccineVehiclesWeather/StormsWeaponryVirusUrbanizationVaccinesUrogenital SystemVirologyZoology/Veterinary Science

Recent Posts

  • Long-hypothesized ‘next generation wonder material’ created for first time
  • Organic farming or flower strips – which is better for bees?
  • Haptics device creates realistic virtual textures
  • Researchers unveil a secret of stronger metals
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....